IP Library Granted Patent US 9,547,004
Granted Patent B2
US 9,547,004 · App. 14/003,277 · Granted Jan 17, 2017

Rapid quantification of biomolecules in a selectively functionalized nanofluidic biosensor and method thereof

Inventors: Nicolas Durand (Vionnaz, CH); Iwan Märki (Yverdon, CH); Stéphane Broillet (Ferlens, CH); Annick Mayor (Morges, CH); Theo Lasser (Denges, CH)
Assignee: ABIONIC SA
G01N33/54373B01L3/502746B01L3/502753B82Y30/00G01N21/6428G01N21/6452B01L2300/0819B01L2300/0877B01L2400/0406B82Y15/00B82Y35/00G01N2021/0346G01N2021/058
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,547,004
App. No.
14/003,277
Granted
Jan 17, 2017
Kind
B2
Abstract

A method and device for the rapid quantification of biomolecules ( 320 ) present in a nanochannel ( 210 ) is claimed. In particular, the present invention relates to a novel concept of liquid actuation and selectively functionalized surfaces in a nanochannel that create a concentration gradient of transitory immobilized biomolecules ( 340 ) across the nanochannel. The present concept enables the quantification of biomolecular interactions of interest ( 320 ).

Claims (9)

1. A biosensor for detecting and quantifying fluorescently-labeled biomolecules; said biosensor comprising a nanochannel defined between two substrates and containing one or more selectively functionalized areas on which are immobilized biomarkers, said nanochannel further defined by a lateral input aperture and a lateral output aperture, said input aperture is designed to allow a solution containing biomolecules to enter said nanochannel, and said output aperture contains or is in contact with a driving component that drives said solution through said nanochannel by capillarity.

2. Biosensor according to claim 1 wherein said biomarkers biologically or chemically interact with specific biomolecules and/or do not interact with non-specific biomolecules contained in said solution.

3. Biosensor according to claim 1 wherein the substrates are made of a material selected from the group consisting of silicon, glass, plastic and oxide compounds.

4. Biosensor according to claim 1 wherein non-functionalized surfaces inside the nanochannel and the lateral apertures contain a thin layer of material selected from the group consisting of metallic, plastic and oxide compounds, having a thickness between 1 nm and 1000 nm.

5. Biosensor according to claim 1 wherein the lateral apertures have an area from 100 nm 2 to 20 mm 2 and the nanochannel a height between 2 nm and 1000 nm, a width between 2 nm and 20 mm, and a length between 2 nm and 20 mm.

6. An array comprising several biosensors as defined in claim 1 , said biosensors being fixed inside a capsule system or on a surface.

7. An assembly comprising one or more biosensors as defined in claim 1 and comprising optical means for fluorescence excitation and detection.

8. The assembly according to claim 7 wherein said optical means is a fluorescence measurement unit comprising a detector which is a single-photon detector.

9. The assembly according to claim 8 wherein the single-photon detector is a detector array (CMOS or CCD), an avalanche photodiode (APD), or a photomultiplier tube (PMT).

Assignments (2)
SECURITY INTEREST Recorded Aug 1, 2023
From: ABIONIC SA
To: SÉVERIN, MARCEL
Reel/Frame 064449/0958 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2013
From: DURAND, NICOLAS; MARKI, IWAN; BROILLET, STEPHANE; MAYOR, ANNICK; LASSER, THEO
To: ABIONIC SA
Reel/Frame 031541/0802 →
Priority Claims (1)
WO PCT/IB2011/050979 · Mar 9, 2011 · international
Continuity (1)
Related Publication 20140256573A1 · Sep 11, 2014